Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis

Leukemia

Volumn 11, Issue 2, 1997, Pages 258-265

  Konig A ^a   Menzel, T ^a   Lynen, S ^a   Wrazel, L ^a   Rosen A ^b   Al Katib, A ^c   Raveche, E ^d   Cabrilove, J L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LINKÖPING UNIVERSITY   (Sweden)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Basic fibroblast growth factor; Bcl 2; Chronic lymphocytic leukemia

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; FLUDARABINE; MESSENGER RNA; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DNA STRAND BREAKAGE; DRUG CYTOTOXICITY; EPSTEIN BARR VIRUS; GENE INDUCTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN INDUCTION; VIRUS CELL TRANSFORMATION;

EID: 0031045135     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400556     Document Type: Article

References (18)

1. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 1987; 8: 95-114.
2. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992; 3: 65-71.
3. Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF, Folkman J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers (see comments). J Natl Cancer Inst 1994; 86: 356-361.
4. Perez-Atayde AR, Sallan SE, Tredow U, Connors S, Folkman J. Spectrum of tumor angiogenesis in bone marrow of children with acute lymphoblastic leukemia. Lab Invest 1995; 72: 141A (Abstr.).
5. Eguchi J, Nomata K, Kanda S, Igawa T, Taide M, Koga S, Matsuya F, Kanetake H, Saito Y. Gene expression and immunohistochem-ical localization of basic fibroblast growth factor in renal cell carcinoma. Biochem Biophys Res Commun 1992; 183: 937-944.
6. Reed JA, McNutt NS, Albino AP. Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Implications for tumor progression. Am J Pathol 1994; 144: 329-336.
7. Nanus DM, Schmitz-Drager BJ, Motzer RJ, Lee AC, Vlamis V, Cordon-Cardo C, Albino AP, Reuter VE. Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. J Natl Cancer Inst 1993; 85: 1597-1599.
8. Menzel T, Rahman Z, Calleja E, White K, Wilson EL, Wieder R, Cabrilove JL. Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine. Blood 1996; 87: 1058-1063.
9. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-306.
10. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-336.
11. Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Epstein AL, Korsmeyer SJ. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chomosome 14 and near a transcriptional unit on 18. Cell 1985; 41: 899-906.
12. Cleary ML, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 1995; 82: 7439-7443.
13. Schena M, Larsson LG, Gottardi D, Gaidano G, Carlsson M, Nilsson K, Caligaris-Cappio F. Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood 1992; 79: 2981-2989.
14. Adachi M, Tefferi A, Greipp PR, Kipps TJ, Tsujimoto Y. Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia. J Exp Med 1990; 171: 559-564.
15. Melo JV, Brito-Babapulle V, Foroni L, Robinson DS, Luzzatto L, Catovsky D. Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement. Int J Cancer 1986; 38: 531-538.
16. Melo JV, Foroni L, Brito-Babapulle V, Luzzatto L, Catovsky D. The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement. Clin Exp Immunol 1988; 73: 23-28.
17. Marti GE, Zenger V, Brown M, Marti DM, Melo JV, Crescenzi M, Dadey B, Han T, Bertin P, Caporaso NE, Noguchi N. Antigenic expression of B-cell chronic lymphocytic leukemic cell lines. Leuk Lymphoma 1992; 7: 497-504.
18. Wendel-Hansen V, Sällström J, De Campos-Lima PO, Kjellström G, Sandlund A, Siegbahn A, Carlsson M, Nilsson K, Rosén A. Epstein-Barr virus (EBV) can immortalize B-CLL cells activated by cytokines. Leukemia 1994; 8: 476-484.